期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
重组人细小病毒B19 VP2病毒样颗粒的制备及免疫原性初步研究 被引量:1
1
作者 侯俊伟 王擎擎 +4 位作者 杜丽芳 梁宇 陈实 栗子谦 李启明 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2020年第12期923-928,共6页
目的利用汉逊酵母系统重组表达人细小病毒B19(human parvovirus B19,B19V)主要衣壳蛋白VP2,并对VP2病毒样颗粒(virus-like particles,VLP)进行理化性质研究及免疫效果评价。方法重组表达B19V VP2蛋白,并使其自组装成VLP;通过高密度发酵... 目的利用汉逊酵母系统重组表达人细小病毒B19(human parvovirus B19,B19V)主要衣壳蛋白VP2,并对VP2病毒样颗粒(virus-like particles,VLP)进行理化性质研究及免疫效果评价。方法重组表达B19V VP2蛋白,并使其自组装成VLP;通过高密度发酵和系列层析纯化步骤获得VP2-VLP;SDS-PAGE和凝胶过滤高效液相色谱检测蛋白质纯度,动态光散射和透射电镜观察颗粒形态,并检测VP2-VLP磷脂酶活性。采用ELISA和红细胞凝集抑制试验检测小鼠体内VP2-VLP特异性IgG抗体和中和抗体水平。结果本研究制备的重组VP2-VLP纯度大于95%,颗粒均一且形态良好,大小近似天然病毒颗粒;VLP可与特异性单克隆抗体结合,磷脂酶A2活性为阴性;吸附佐剂后的VP2-VLP能够诱导小鼠产生高滴度的特异性IgG抗体和中和抗体。结论汉逊酵母表达系统制备的B19V VP2-VLP可作为候选靶抗原用于B19V预防性疫苗的开发。 展开更多
关键词 人细小病毒B19 病毒样颗粒 红细胞凝集抑制试验
原文传递
Accelerated Evolution of H7N9 Subtype Influenza Virus under Vaccination Pressure
2
作者 Yifan Wu Jingkai Hu +8 位作者 Xuanjiang Jin Xiao Li Jinfeng Wang Mengmeng Zhang Jianglin Chen Shumin Xie Wenbao Qi Ming Liao Weixin Jia 《Virologica Sinica》 SCIE CAS CSCD 2021年第5期1124-1132,共9页
No avian H7 N9 outbreaks have occurred since the introduction of H7 N9 inactivated vaccine in the fall of 2017.However,H7 N9 is still prevalent in poultry.To surveil the prevalence,genetic characteristics,and antigeni... No avian H7 N9 outbreaks have occurred since the introduction of H7 N9 inactivated vaccine in the fall of 2017.However,H7 N9 is still prevalent in poultry.To surveil the prevalence,genetic characteristics,and antigenic changes of H7 N9,over7000 oropharyngeal and cloaca swab specimens were collected from live poultry markets and farms in 15 provinces of China from 2017 to 2019.A total of 85 influenza virus subtype H7 N9 strains were isolated and 20 representative strains were selected for genetic analysis and antigenicity evaluation.Results indicated the decreased prevalence of low-pathogenic H7 N9 strains while highly-pathogenic H7 N9 strains became dominated since the introduction of vaccine.Phylogenetic analysis showed that strains from 2019 formed an independent small branch and were genetically distant to strains isolated in 2013–2018.Analysis of key amino acid sites showed that the virus strains may adapt to the host environment evolutionally through mutation.Our analysis predicted additional potential glycosylation sites for HA and NA genes in the 2019 strains.Sequence analysis of HA gene in strains isolated from 2018 to 2019 showed that there were an increased nucleotide substitution rate and an increased mutation rate in the first and second nucleotides of coding codons within the open reading frame.The hemagglutination inhibition(HI)assay showed that H7-Re1 and H7-Re2 exhibited a lower HI titer for isolates from 2019,while H7-Re3 and r LN79 showed a high HI titer.The protective effect of the vaccine decreased after15 months of use.Overall,under vaccination pressure,the evolution of influenza virus subtype H7 N9 has accelerated. 展开更多
关键词 H7N9 Genetic evolution Epidemiological investigation hemagglutination inhibition assay Vaccination pressure
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部